Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Arnold Wald, MD The American Gastroenterological Association released updated guidelines for patients with irritable bowel syndrome with constipation (IBS-C). To find out more about the latest updates in treatment, Dr. Peter Buch dives into these guideline recommendations with Dr. Arnold Wald, a Professor of Medicine at the University of Wisconsin.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Feuerstadt, MD, FACG, AGAF In the United States, about 80 percent of tests used to diagnose C. difficile are PCR assays. So what are the best options to diagnose and treat patients with this infection? To discuss the evolving treatment and evaluation landscape for C. difficile, Dr. Peter Buch is joined by Dr. Paul Feuerstadt, Assistant Clinical Professor at Yale New Haven Hospital.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Robert Battat, MDCM, FRCPC A kay cofounder in managing postoperative Crohn’s disease, bile acid diarrhea can be challenging to diagnose. What tests are currently available? To discuss this cofounder and how to diagnose it, Dr. Peter Buch sits down with Dr. Robert Battat, the Director of the Center for Clinical and Translational Research for Inflammatory Bowel Disease at the University of Montreal.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Robert Battat, MDCM, FRCPC What confounders do we face when managing postoperative Crohn’s disease, and what tools do we have available to us? Dr. Peter Buch dives into this topic with Dr. Robert Battat, the Director of the Center for Clinical and Translational Research for Inflammatory Bowel Disease at the University of Montreal.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Daniel Strand, MD Acute pancreatitis can be tricky to diagnose and treat. To help us understand how to better manage this condition, Dr. Peter Buch is joined by Dr. Daniel Strand, the Director of Pancreatobiliary Endoscopy at UVA Health in Charlottesville and an Associate Professor of GI Hepatology to share management updates for patients with recurrent acute and chronic pancreatitis.
Host: Neilanjan Nandi, MD Guest: Andres Yarur, MD Irritable bowel disease (IBD) often requires a personalized approach to treatment. So what does the current therapeutic drug monitoring landscape look like? Dr. Neil Nandi speaks with Dr. Andres Yarur, Associate Professor of Medicine at Cedars-Sinai in Los Angeles, about therapeutic drug monitoring for IBD.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Justin R Boike, MD, MPH The procedure of transjugular intrahepatic portosystemic shunt (TIPS) is a crucial therapeutic option when treating patients with complications of portal hypertension. So what do we need to know about this procedure? To further delve into TIPS, Dr. Peter Buch is joined by Dr. Justin Boike, Assistant Professor of Medicine at the Northwestern University Feinberg School of Medicine.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Aline Charabaty, MD Given what medications are currently available, inflammatory bowel disease (IBD) can be difficult to manage. What do we need to know about them, and how do we know which of our patients are the right candidates for them? To answer this question, Dr. Peter Buch speaks with Dr. Aline Charabaty from the Sibley Memorial Hospital.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Ira M. Jacobson, MD What do the guidelines recommend for hepatitis B vaccination? Dr. Peter Buch joins Dr. Ira Jacobson, Director of Hepatology and Professor of Medicine at NYU Langone Health and NYU Grossman School of Medicine, to explore challenges and guidelines for hepatitis B vaccination.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Aasma Shaukat, MD, MPH Adenoma detection rate (ADR) may help us better detect our patients’ risk of developing colorectal cancer. To explore what we need to know about this quality indicator, Dr. Peter Buch joins Dr. Aasma Shaukat from the New York University Grossman School of Medicine to talk about ADR.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Sara Horst, MD, MPH, FACG Ulcerative colitis (UC) has an evolving treatment landscape, which has made it difficult for clinicians to position treatment options for their patients. What’s currently available? Dr. Peter Buch dives into this rapidly changing treatment landscape with Dr. Sara Horst, an Associate Professor at Vanderbilt University.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Eamonn Quigley, MD New recommendations about the pharmacological management of irritable bowel syndrome (IBS) with diarrhea by the American Gastroenterological Association (AGA) was published in Gastroenterology 2022. So what do we need to know about these updates, and which medications should we be using? To provide insight, Dr. Peter Buch is joined by Dr. Eamonn Quigley, the David M Underwood Chair of Medicine in Digestive Disorders and Professor o...
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David Leiman, MD, MSHP Proton pump inhibitors (PPIs) are among the most commonly prescribed class of medication for acid-related disorders. But what are the long-term consequences of PPIs? And how have they changed the prescribing pattern among gastroenterologists? To help us better understand this topic, Dr. David Leiman, Assistant Professor of Medicine at Duke University School of Medicine, joins Dr. Peter Buch to discuss how we should be utilizing...
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Benjamin L. Cohen, MD Guest: Stefan Holubar, MD, MS New data suggests that the use of anti-TNF therapy early in the treatment course can be effective for patients with inflammatory bowel disease (IBD). However, some of them may still require surgery. But is anti-TNF therapy safe in the perioperative period? To answer this question, Dr. Peter Buch is joined by Drs. Benjamin Cohen and Stefan Holubar from the Cleveland Clinic to discuss the findings fro...
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Victoria Gomez, MD Endoscopic sleeve gastroplasty may be an effective option for weight loss. But which of our patients are the right candidates—and what do they need to know about before and after the procedure? Dr. Peter Buch dives into this procedure with Dr. Victoria Gomez, an Associate Professor of Medicine at the Mayo Clinic in Florida.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michel Kahaleh, MD Endoscopic ultrasound-guided gallbladder drainage (ESU) is used to treat patients with cholecystitis and infection of the gallbladder. So when should we be utilizing ESU, and what are some common challenges associated with this procedure? Joining Dr. Peter Buch to explore this topic is Dr. Michel Kahaleh, Chief of Endoscopy, Director of the Pancreas Program, and Medical Director of the Advanced Endoscopy Research Program at Robert ...
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Madhu Grover, MBBS Gastroparesis is a complex disease that has limited treatment options. What do we need to know about it? Dr. Mandu Grover, an Associate Professor of Medicine at the Mayo Clinic, joins Dr. Peter Buch to discuss gastroparesis.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Madhu Grover, MBBS Gastroparesis can be a complex disease to understand—and treat. What therapeutics are currently available? Dr. Peter Buch is joined by Dr. Mandu Grover, an Associate Professor of Medicine at the Mayo Clinic, to take a look at current treatment options.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Eamonn Quigley, MD What factors affect the microbiome? And who should we be prescribing probiotics to? Find out the answers to those and other key questions with Dr. Peter Buch and returning guest Dr. Eamonn Quigley, Professor of Medicine and Chief of the Division of Gastroenterology and Hepatology at Weill Cornell Medical College at Houston Methodist Hospital.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Sarah McGill, MD, MSc Alpha-gal allergy is a recently identified food allergy to red meat and other products made by mammals. So what more do we need to know about this new allergy, and which of our patients are at risk for anaphylaxis? To dive into this topic, Dr. Peter Buch is joined by Dr. Sarah McGill, Associate Professor of Medicine at the University of North Carolina, to discuss her recent research on alpha-gal allergy....
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: William Chey, MD The role of diet and nutrition in irritable bowel syndrome (IBS) has long been established, but clinical updates are always evolving. That’s why Dr. Peter Buch welcomes Dr. William Chey, Professor of Medicine and Chief of Gastroenterology at the University of Michigan, to talk about the latest clinical updates from the American Gastroenterological Association.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Reena Chokshi, MD Gastric emptying tests may be used for patients with gastroparesis and functional dyspepsia. But when it comes to assessing patients with symptoms, is it time to discard these tests? Find out with Dr. Peter Buch as he speaks with Dr. Reena Chokshi, Assistant Professor at Baylor College of Medicine and author of an editorial on this topic, titled Is It Time to Abandon Gastric Emptying in Patients With Symptoms of Gastroparesis and Fu...
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Maurizio Bonacini, MD What non-invasive techniques are available to assess liver fibrosis? Joining Dr. Peter Buch to give us insight on this key question, along with how we can incorporate these treatments into our patient care, is Dr. Maurizio Bonacini. Dr. Bonacini is an Associate Professor of Clinical Medicine at the University of California, San Francisco and CEO of Mission Gastroenterology and Hepatology.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Robert Wong, MD What are our treatment options for hepatitis B, and do they have any limitations? Here to walk us through the challenges treatment landscape for hepatitis B is Dr. Robert Wong, who is a Clinical Associate Professor at Stanford University.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Mark Pimentel, MD Hydrogen breath tests can help clinicians determine if a patient has conditions that can affect their digestive health, and they’re especially important for the diagnosis of carbohydrate maldigestion and small intestinal bacterial overgrowth. That’s why Dr. Peter Buch takes an in-depth look at breath testing with Dr. Mark Pimentel, Professor of Medicine at the David Geffen School of Medicine at UCLA and Associate Professor at Cedars...
Host: Neilanjan Nandi, MD Guest: Parambir Dulai, MD In contrast to traditional monoclonal antibodies or small molecules, hyperbaric oxygen therapy involves a different type of treatment. But is this therapeutic option effective for our ulcerative colitis patients? To better understand this, Dr. Neil Nandi speaks with Dr. Parambir Dulai from Northwestern University to share his research on hyperbaric oxygen therapy.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Eamonn Quigley, MD Have you ever wondered what the practice of gastroenterology will look like in 10 years? If so, you’re not alone. And to help clear up that crystal ball, Dr. Peter Buch speaks with Dr. Eamonn Quigley about what’s to come in gastroenterology.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Kwo, MD The treatment landscapes for alcoholic hepatitis and acute kidney injury in cirrhosis are evolving. So how are we now defining acute kidney injury with cirrhosis, and how should we treat these two conditions based on the latest therapeutic updates? To find out, Dr. Peter Buch speaks with Dr. Paul Kwo, Professor of Medicine and Director of Hepatology at Stanford University.
Guest: Todd H. Baron, MD What do we need to know about esophageal perforations? Dr. Todd H. Baron from the University of North Carolina School of Medicine shares how he treats patients with esophageal perforations.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Brennan Spiegel, MD, MSHS Diverticular disease is a common condition for which clinical therapies continue to evolve. So what has changed in the treatment paradigm? Joining Dr. Peter Buch to discuss everything from the role of colonoscopy, diverticular bleeding, long-term complications, and more is Dr. Brennan Spiegel, Director of Health Services Research at Cedars-Sinai and Professor of Medicine at UCLA.
